Equity Details
Price & Market Data
Price: $3.11
Daily Change: +$0.13 / 4.18%
Daily Range: $3.00 - $3.11
Market Cap: $13,993,168
Daily Volume: 22,285
Performance Metrics
1 Week: 2.30%
1 Month: 34.63%
3 Months: 1.97%
6 Months: -4.89%
1 Year: 0.65%
YTD: 12.27%
About BioLineRx Ltd. (BLRX)
Analyze the market position of BioLineRx Ltd. (BLRX). With a current price of 3.11, the stock exhibits a +$0.13 / 4.18% daily trend. A market capitalization of 13,993,168 indicates its scale. Discover its performance over 1-month (34.63%) and 3-month (1.97%) periods.
Company Details
Employees: 24
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.